Home
Browse
Search
Statistics
About
Usage
PMID: 12391288
Gruol DJ, King MN, Kuehne ME
Evidence for the locations of distinct steroid and Vinca alkaloid interaction domains within the murine mdr1b P-glycoprotein.
Mol Pharmacol. 2002 Nov;62(5):1238-48.,
[PubMed]
Sentences
No.
Mutations
Sentence
Comment
117
ABCB1 p.Ala301Thr
X
ABCB1 p.Ala301Thr 12391288:117:53
status:
NEW
view ABCB1 p.Ala301Thr details
ABCB1 p.Ala301Val
X
ABCB1 p.Ala301Val 12391288:117:63
status:
NEW
view ABCB1 p.Ala301Val details
ABCB1 p.Ala301Asp
X
ABCB1 p.Ala301Asp 12391288:117:4
status:
NEW
view ABCB1 p.Ala301Asp details
The
A301D
mutation occurs in the same residue as the
A301T
and
A301V
mutations.
Login to comment
119
ABCB1 p.Ala229Val
X
ABCB1 p.Ala229Val 12391288:119:42
status:
NEW
view ABCB1 p.Ala229Val details
It contains two closely spaced mutations,
A229V
and W231L.
Login to comment
127
ABCB1 p.Ala229Val
X
ABCB1 p.Ala229Val 12391288:127:67
status:
NEW
view ABCB1 p.Ala229Val details
In total, the process identified five new mutations, two of which (
A229V
, S308L) involve amino acids that had not been previously identified as contributing to steroid interactions with the P-gp.
Login to comment
131
ABCB1 p.Ala301Asp
X
ABCB1 p.Ala301Asp 12391288:131:331
status:
NEW
view ABCB1 p.Ala301Asp details
ABCB1 p.Ala229Val
X
ABCB1 p.Ala229Val 12391288:131:292
status:
NEW
view ABCB1 p.Ala229Val details
The percentage of normalized change in resistance (N.C.R) is defined by the equation: N.C.R ϭ 100% ϫ (VAR IC50 - MS23IC50 )/(MS23 IC50 - W7TB IC50) Cell Line Vincristine Daunomycin Dexamethasone Puromycin Colchicine Mutation MSPD-10 N.C. ` ``` `` `` W231C MSPT-7 `` ``` ``` ``` `
A229V
, W231L MSPD-60 `` N.C. ``` `` ``
A301D
MSMP-1 ` `` `` `` ``` S308L MSAC-52 ` N.C. `` N.C. ϩϩϩϩ L338F N.C., no change; ϩϩϩϩ, NCR increase Ն200%; `, NCR decrease Ն33%; ``, Ն67%; ```, Ն100%.
Login to comment
153
ABCB1 p.Ala301Asp
X
ABCB1 p.Ala301Asp 12391288:153:50
status:
NEW
view ABCB1 p.Ala301Asp details
Daunomycin was used to evaluate the effect of the
A301D
mutation, expressed in the MSPD-60 cells, on the inhibitory activity of 5betaPodo.
Login to comment
169
ABCB1 p.Trp232Cys
X
ABCB1 p.Trp232Cys 12391288:169:49
status:
NEW
view ABCB1 p.Trp232Cys details
In the human protein, the comparable mutation is
W232C
.
Login to comment
172
ABCB1 p.Leu339Cys
X
ABCB1 p.Leu339Cys 12391288:172:19
status:
NEW
view ABCB1 p.Leu339Cys details
However, the human
L339C
mutation produced a nearly complete loss of the ability of methanethiosulfonate-verapamil to induce ATPase activity.
Login to comment
179
ABCB1 p.Ser228Thr
X
ABCB1 p.Ser228Thr 12391288:179:45
status:
NEW
view ABCB1 p.Ser228Thr details
The most pronounced effect was caused by the
S228T
mutation expressed in the MSPP-21 cells.
Login to comment
204
ABCB1 p.Ala301Val
X
ABCB1 p.Ala301Val 12391288:204:44
status:
NEW
view ABCB1 p.Ala301Val details
The mutation expressed in the MSPP-4 cells (
A301V
) shows the largest reduction of MEK-417 inhibitory activity.
Login to comment
206
ABCB1 p.Ala301Val
X
ABCB1 p.Ala301Val 12391288:206:34
status:
NEW
view ABCB1 p.Ala301Val details
Thus, it seems unlikely that the (
A301V
) mutation interferes with the initial binding of Vinca alkaloids with the protein.
Login to comment
207
ABCB1 p.Ala301Val
X
ABCB1 p.Ala301Val 12391288:207:20
status:
NEW
view ABCB1 p.Ala301Val details
It is possible that
A301V
promotes the transport of MEK-417 also, which would lead to lower inhibitory activity.
Login to comment
298
ABCB1 p.Ala301Thr
X
ABCB1 p.Ala301Thr 12391288:298:63
status:
NEW
view ABCB1 p.Ala301Thr details
ABCB1 p.Ala301Val
X
ABCB1 p.Ala301Val 12391288:298:56
status:
NEW
view ABCB1 p.Ala301Val details
ABCB1 p.Ala301Asp
X
ABCB1 p.Ala301Asp 12391288:298:70
status:
NEW
view ABCB1 p.Ala301Asp details
Multiple mutations were also found at the A301 residue (
A301V
,
A301T
,
A301D
), although much less frequently than the changes at W231.
Login to comment